- Engage with senior executives from prominent life sciences companies, CROs and healthcare providers
- 75% of attendees in 2022 had a job title of 'Head of' or above, so true decision-makers will be on site
- Schedule 1-to-1 meetings with leaders in the online event community
- Establish new relationships and strengthen ties at our evening drinks reception
- FT editors and other global press outlets will be there
US Pharma and Biotech Summit
The Financial Times US Pharma and Biotech Summit returns in May 2023 for two days of insightful analysis and discussion on key topics including drug discovery, clinical trials, market access, portfolio management and stakeholder engagement.
As pharmaceutical and biotechnology companies continue to innovate in a disrupted world, industry leaders will gather in New York to address the challenges and opportunities of today and tomorrow, from building partnerships and investing in technology to developing new treatments and preparing for the next global health emergency.
Join us in-person and online as we explore new frontiers for business and for healthcare. Learn from renowned experts, engage with prominent CEOs and network with peers in a friendly but focused environment.
How pharma’s role in American healthcare is evolving through innovation in R&D, drug delivery and patient access
With some of the biggest names in the industry to learn about the latest trends, exchange ideas and build relationships
New approaches to drug development with the potential to transform pipelines and bring products to market faster
Where are investors in American life sciences putting their money?
How can public and private stakeholders collaborate beyond the pandemic?
What are some of the latest breakthroughs in advanced therapies?
How are pharma and biotech operating models evolving?
How is the approval process for drugs evolving in the US?
Why is patient centricity important?
The Power of Networking
Become a Sponsor
Contact email@example.com to discuss partnership opportunities that work best for you and your business objectives. Engage directly with influential leaders and organizations across the industry.
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice